SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15627033
Source:
http://linkedlifedata.com/resource/pubmed/id/15627033
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019704
,
umls-concept:C0023977
,
umls-concept:C0030705
,
umls-concept:C0205470
,
umls-concept:C0243009
,
umls-concept:C0347983
,
umls-concept:C1512900
,
umls-concept:C2745888
pubmed:issue
1
pubmed:dateCreated
2004-12-31
pubmed:abstractText
To analyse immunological markers associated with CD4+ lymphocyte T-cell count (CD4+) evolution during 12-month follow-up after treatment discontinuation.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD
,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0269-9370
pubmed:author
pubmed-author:BlancoPatrickP
,
pubmed-author:ChêneGenevièveG
,
pubmed-author:FleuryHervéH
,
pubmed-author:MoreauJean FrançoisJF
,
pubmed-author:PellegrinIsabelleI
,
pubmed-author:PellegrinJean LucJL
,
pubmed-author:ThiébautRodolpheR
,
pubmed-author:ViallardJean FrançoisJF
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
53-61
pubmed:meshHeading
pubmed-meshheading:15627033-Adult
,
pubmed-meshheading:15627033-Antigens, CD
,
pubmed-meshheading:15627033-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:15627033-Biological Markers
,
pubmed-meshheading:15627033-CD4 Lymphocyte Count
,
pubmed-meshheading:15627033-CD4-Positive T-Lymphocytes
,
pubmed-meshheading:15627033-Chronic Disease
,
pubmed-meshheading:15627033-Dendritic Cells
,
pubmed-meshheading:15627033-Female
,
pubmed-meshheading:15627033-HIV Infections
,
pubmed-meshheading:15627033-HIV-1
,
pubmed-meshheading:15627033-Humans
,
pubmed-meshheading:15627033-Male
,
pubmed-meshheading:15627033-Middle Aged
,
pubmed-meshheading:15627033-Prospective Studies
,
pubmed-meshheading:15627033-RNA, Viral
,
pubmed-meshheading:15627033-Time Factors
,
pubmed-meshheading:15627033-Viral Load
,
pubmed-meshheading:15627033-Withholding Treatment
pubmed:year
2005
pubmed:articleTitle
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.
pubmed:affiliation
INSERM E0338 & U593, ISPED, Université Bordeaux 2, Bordeaux Cedex, France. rodolphe.thiebaut@isped.u-bordeaux2.fr
pubmed:publicationType
Journal Article